These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30390352)
1. Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease. Zhang H; Niu Y; Gu H; Lu S; Zhang W; Li X; Yang Z; Qin L; Su Q J Clin Lab Anal; 2019 Mar; 33(3):e22709. PubMed ID: 30390352 [TBL] [Abstract][Full Text] [Related]
2. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. Ke F; Xue G; Jiang X; Li F; Lai X; Zhang M; Shen Y; Gao L Cytokine; 2020 Oct; 134():155184. PubMed ID: 32645536 [TBL] [Abstract][Full Text] [Related]
3. Association of hypoadiponectinemia with non-alcoholic fatty liver disease in urban south Indians--(CURES - 81). Gokulakrishnan K; Anjana RM; Indulekha K; Anuradha S; Mohan V Indian J Med Res; 2010 Sep; 132():271-7. PubMed ID: 20847373 [TBL] [Abstract][Full Text] [Related]
4. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. Hossain IA; Rahman Shah MM; Rahman MK; Ali L Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965 [TBL] [Abstract][Full Text] [Related]
5. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease. Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome. Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240 [TBL] [Abstract][Full Text] [Related]
7. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses. Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136 [TBL] [Abstract][Full Text] [Related]
8. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302 [TBL] [Abstract][Full Text] [Related]
9. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671 [TBL] [Abstract][Full Text] [Related]
10. Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects. Hossain IA; Akter S; Rahman MK; Ali L PLoS One; 2015; 10(11):e0142165. PubMed ID: 26569494 [TBL] [Abstract][Full Text] [Related]
11. Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study. Xiao ML; Chen GD; Zeng FF; Qiu R; Shi WQ; Lin JS; Cao Y; Li HB; Ling WH; Chen YM Eur J Nutr; 2019 Mar; 58(2):721-730. PubMed ID: 29594435 [TBL] [Abstract][Full Text] [Related]
12. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. Angın Y; Arslan N; Kuralay F Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597 [TBL] [Abstract][Full Text] [Related]
13. Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study. Qiu Y; Wang SF; Yu C; Chen Q; Jiang R; Pei L; Huang YL; Pang NZ; Zhang Z; Ling W; Yang L Ann Nutr Metab; 2019; 74(1):44-52. PubMed ID: 30541001 [TBL] [Abstract][Full Text] [Related]
14. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases]. Xu L; Zhong Y; Su ST; Liu YG; Lyu FN; Zhou XL; Ren JQ; Li P; Shi RF; Jiang Y; Fan JG; Mi YQ Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):247-253. PubMed ID: 32306658 [No Abstract] [Full Text] [Related]
15. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253 [TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma? Abdel-Razik A; Mousa N; Shabana W; Refaey M; Elhelaly R; Elzehery R; Abdelsalam M; Elgamal A; Nassar MR; Abu El-Soud A; Seif AS; Tawfik AM; El-Wakeel N; Eldars W Helicobacter; 2018 Dec; 23(6):e12537. PubMed ID: 30246507 [TBL] [Abstract][Full Text] [Related]
17. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? Sargin H; Sargin M; Gozu H; Orcun A; Baloglu G; Ozisik M; Seker M; Uygur-Bayramicli O World J Gastroenterol; 2005 Oct; 11(37):5874-7. PubMed ID: 16270401 [TBL] [Abstract][Full Text] [Related]
18. Elevated levels of serum uric acid and insulin resistance are associated with nonalcoholic fatty liver disease among prediabetic subjects. Hossain IA; Faruque MO; Akter S; Bhuiyan FR; Rahman MK; Ali L Trop Gastroenterol; 2016; 37(2):101-11. PubMed ID: 30234279 [TBL] [Abstract][Full Text] [Related]
19. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. Abenavoli L; Luigiano C; Guzzi PH; Milic N; Morace C; Stelitano L; Consolo P; Miraglia S; Fagoonee S; Virgilio C; Luzza F; De Lorenzo A; Pellicano R Panminerva Med; 2014 Jun; 56(2):189-93. PubMed ID: 24994581 [TBL] [Abstract][Full Text] [Related]
20. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease. Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]